England: New Free of Charge (FoC) medicine guidelines

 

In recent months, England introduced guidelines for free-of-charge medicine schemes to ensure consistency across integrated care system.

These guidelines aim to prevent distorted geographical prescribing patterns. Omar, with extensive experience in the UK, recalls some companies offering free medicines until NICE evaluations were completed, leading to tensions between clinicians and payers over potential future liabilities. The new guidelines aim to prevent localised free-of-charge offers, but keeps the door open for manufacturers to offer national national schemes.

An extract from September’s EU/UK/Asia session of Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting, in EU, UK and Asia regions.

Register here for future events


Disclaimer: This presentation is for discussion purposes only, and is not intended as legal or policy advice. This presentation is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this webinar may be reproduced for commercial purposes without the express permission of Verpora.

 

Speakers

Omar Ali
Head of Payers, Verpora
LinkedIn

Adam Meads
Head of Research & Analytics, Verpora
LinkedIn

Previous
Previous

Turkey: The impact of the alternative reimbursement legislation

Next
Next

Spain: Is this the end for IPT plans?